Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Andrew Morrow, M.D.

Co-Author

This page shows the publications co-authored by David Morrow and Peter Libby.
Connection Strength

0.225
  1. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J. 2008 Jan; 155(1):49-55.
    View in: PubMed
    Score: 0.094
  2. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2192-6.
    View in: PubMed
    Score: 0.081
  3. Myocardial infarction accelerates atherosclerosis. Nature. 2012 Jul 19; 487(7407):325-9.
    View in: PubMed
    Score: 0.033
  4. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 2003 Sep 02; 108(9):1049-52.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.